Zobrazeno 1 - 10
of 131
pro vyhledávání: '"H.K. Stummvoll"'
Autor:
K. Arneitz, M. Wallner, Alice Schmidt, Nilgün Yilmaz, M. Auinger, H.K. Stummvoll, Martin Haas, I. Arias, Gert Mayer, Ulrich Neyer, B. Schneider
Publikováno v:
Kidney and Blood Pressure Research. 21:66-69
Angiotensin-converting enzyme (ACE) inhibitors are known to reduce blood pressure and proteinuria in a variety of different glomerular diseases. Nonetheless, a marked interindividual difference in the efficacy of these agents exists. The activity of
Publikováno v:
Nephron. 28:209-212
Glycosylated hemoglobin A (HbA1), a proposed indicator of the integrated plasma glucose concentration over a long period of time, was investigated in patients with various degrees of renal
Autor:
S O'Regan, M. Mosawi, P.B. Disler, W.R. Bezwoda, Norman L.M. Wong, Helmut Graf, Gerald T. Keusch, E. Bourke, D. Kiss, J. D. Torrance, D.P. Derman, A.M. Meyers, Héctor F. Konopka, Volker Wizemann, L. Eales, V.B. Delaney, Julio C. Sanchez Avalos, Roger A.L. Sutton, Robert P. Langlois, H. Heule, P. Reavey, A. Wolf, M. Weissel, Claudio C. Marone, G. Schütterle, N Tartas, A P MacPhail, U. Binswanger, M. Weston, Micheline Pelletier, Josef Kovarik, H.W. Birk, Pierre Robitaille, Mario A. Nicastro, Joseph Levin, Thomas H. Bothwell, Alberto J. Monserrat, Arturo M. Musso, F. Bammatter, F.J. Milne, R. S. Day, Pinggera Wf, Ibis Arienti di García, John H. Dirks, H.K. Stummvoll
Publikováno v:
Nephron. 28:I-IV
Publikováno v:
Nephron. 37:180-185
Patients with end-stage kidney disease undergoing chronic maintenance dialysis (HD) are a high risk group for sudden death due to cardiovascular complications. It was the aim of the study to investigate the quantity and quality of arrhythmias during
Publikováno v:
Nephron. 28:285-288
1α-hydroxycholecalciferol was tried as a therapy for renal phosphate wasting in kidney allograft recipients with normal parathyroid gland activity. During a 3-week period of treatment we observed a si
Publikováno v:
Nephron. 51:34-38
In earlier studies we have shown that partial correction of anemia by recombinant human erythropoietin (r-HuEPO) already after 12 weeks results in a significant increase of exercise capacity in patients on chronic hemodialysis. As causative effect in
Publikováno v:
Nephron. 34(2)
Publikováno v:
British medical journal. 2(6203)
Autor:
M. Weissel, E. Zimmermann, F. Kaiser, R. Puchegger, H.K. Stummvoll, Josef Kovarik, I. Fasching
Publikováno v:
Nephron. 44(3)
Thyroid hormone (free and total thyroxine, total 3,5,3'- and 3,3'5'-triiodothyronine, thyroxine-binding globulin, thyrotropin) serum concentrations were measured in 107 uremic patients of 4 hemodialysis centers, in order to study the prevalence of hy